presence of the virus itself. The FDA has approved routine HPV testing in women age 30 and older - the group most likely to have persistent infections and most at risk of cervical cancer. In addition, vaccines are in development and are designed to protect those inoculated if they have not yet been exposed to the virus. However, screening will still be necessary, since the vaccines now being researched only target some of the several types of HPV that may trigger cervical cancer.
About the Association of Reproductive Health Professionals
The Association of Reproductive Health Professionals (ARHP) is a multidisciplinary non-profit association composed of professionals who provide reproductive health services or education, conduct reproductive health research, or influence reproductive health policy. Founded in 1963, ARHP's mission is to educate health care professionals, public policy makers, and the public. The organization fosters research and advocacy to promote reproductive health. To learn more about ARHP, visit www.arhp.org.
For more information about the HPV survey visit www.arhp.org/HPVsurvey. To learn more about cervical cancer prevention visit www.arhp.org/cervicalcancer.
The survey was supported by an unrestricted educational grant from Digene Corporation.
'"/>Source:
Lippe Taylor
Page: 1 2 3 Related biology news :1.
Survey finds silver contamination in North Pacific waters2.
Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research3.
A bacterial genome reveals new targets to combat infectious disease4.
First real-time view of developing neurons reveals surprises, say Stanford researchers5.
Examination of internal wiring of yeast, worm, and fly reveals conserved circuits6.
NYU study reveals how brains immune system fights viral encephalitis7.
Study reveals new technique for fingerprinting environmental samples8.
Study reveals dramatic difference between breast cancers in US and Africa9.
UCSD research reveals mechanism involved with type of fatal epilepsy10.
Study reveals candidate targets for anti-retroviral therapeutics11.
Chimp genome reveals a retroviral invasion